Dr. Laurencin will be the Kavli Distinguished Lecturer and Plenary Speaker at The Materials Research Society (MRS) Spring 2016 meeting (28-March through 1-April, 2016) in Phoenix, AZ. Additionally, he will be receiving the Society for Biomaterials Founder’s Award at the World Biomaterials Congress (17-22 May, 2016) in Montreal, QC, where the first Cato T. Laurencin Travelling Fellows will also be presented.
A: In both cases I think that we are in a transformational period for both areas of scientific inquiry. For health disparities, there really isn’t an international publisher of scholarly articles on racial and ethnic health disparities like Springer and health disparities I think will define medicine in the 21st century. For Regenerative Engineering, we feel we are at the dawn of a new field. We anticipate great things.
A: First it is setting up a team. Managing editors and other supporting staff are important. Second is a dedicated group of editorial board members who can review papers, and also spread the word about the journal. Third is aggressive advertising by the publisher at meetings and other venues that are important for the journal.
A: I think having the response level that one wishes early on can be an area of setback. There has to be vigilance in promoting the journal by the editor, the staff, and the publisher. At the start of a new journal, one can’t be too comfortable.
A: Very few cons except that you have to find a publisher that shares your passion for the subject. We actually turned down other publishers before working with Springer on both journals. We felt that they shared our commitment and passion.
A: They are very similar except with a social sciences journal there are early decisions to be made in terms of how quantitative/qualitative the data can be, and how broadly one defines the area.
A: We had a lot of discussion with people before the launch, and really directed people to the website at the earliest possible time. The process of promotion of the journal is a continuing one.
A: Our first journal (Racial and Ethnic Health Disparities) has just been accepted for listing on Medline. Only 15 percent of journals are accepted on first application. That’s a tremendous accomplishment. We now have a backlog of about two issues in publishing which reflects tremendous interest. We are hoping for the same for our newest journal.
A: I picked very smart, dedicated and hard-working people. That is the key to success in any venture.
A: Just Do It!
Cato T. Laurencin, MD, PhD is the Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery and Professor of Chemical Engineering, Materials Science and Engineering, as well as Biomedical Engineering at the University of Connecticut. In addition, UConn named him a University Professor, the 8th in its 130-year history. He is the founder and director of the Institute for Regenerative Engineering and the Sackler Center for Biomedical, Biological, Physical and Engineering Sciences at UConn Health.
Dr. Laurencin earned his undergraduate degree in chemical engineering from Princeton University, his medical degree magna cum laude from Harvard Medical School, and his Ph.D. in biochemical engineering/biotechnology from the Massachusetts Institute of Technology.
Dr. Laurencin is the first orthopaedic surgeon elected to membership in both the National Academy of Medicine and the National Academy of Engineering. He is a recipient of the National Medal of Technology and Innovation, the nation’s highest award for technological innovation.
Get in touch with one of our editors today.